Evolus, Inc.
EOLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001570562
In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Evolus, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 123 | 130 | +7 |
| Shares | 25.4M | 25.6M | +188.8K (+0.7%) |
| Value | $294.2M | $205.7M | −$88.5M (−30.1%) |
New holders (26)
Institutions that held Evolus, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (19)
Institutions that held Evolus, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Soleus Capital Management, L.P. | 810,676 | $9.40M |
| EAM Investors, LLC | 405,341 | $4.70M |
| Tri Locum Partners LP | 217,767 | $2.53M |
| EAM Global Investors LLC | 200,007 | $2.32M |
| Monarch Partners Asset Management LLC | 81,069 | $940.0K |
| Ikarian Capital, LLC | 45,516 | $529.0K |
| Two Sigma Investments, LP | 31,621 | $367.0K |
| Engineers Gate Manager LP | 23,870 | $277.0K |
| Group One Trading, L.P. | 22,138 | $257.0K |
| AdvisorShares Investments LLC | 17,030 | $198.0K |
| Renaissance Technologies LLC | 12,400 | $144.0K |
| Caxton Associates LP | 11,719 | $136.0K |
| PEAK6 Investments LLC | 15,441 | $112.3K |
| Tradition Wealth Management, LLC | 5,500 | $64.0K |
| Altshuler Shaham Ltd | 2,296 | $27.0K |
| Captrust Financial Advisors | 1,265 | $15.0K |
| Zullo Investment Group, Inc. | 700 | $8.00K |
| Quadrant Capital Group LLC | 161 | $2.00K |
| Ellevest, Inc. | 37 | $0 |